Detection of Vocal Fold Motion Impairment on Noninvasive Positive Pressure
Point-of-Care Ultrasound to Detect Vocal Fold Motion Impairment on Pediatric Patients on Noninvasive Positive Pressure Ventilation
Northwell Health
50 participants
Mar 30, 2024
OBSERVATIONAL
Conditions
Summary
The goal of this prospective, observational study is to evaluate for the presence of vocal fold motion impairment (VFMI) in the children admitted to the pediatric intensive care unit on noninvasive positive pressure ventilation (NIV PPV). Participants will have two ultrasounds of their vocal folds performed, once while on NIV PPV and once after weaned off of the NIV PPV. This results of these scans will be reviewed against one another and against the gold standard, fiberoptic nasolaryngoscopy (FNL). The main question this study aims to answer is: Can POCUS be used to reliably detect VFMI while pediatric patients on supported with NIV PPV?
Eligibility
Inclusion Criteria3
- Age 0 to 18 years
- Scheduled to receive a fiberoptic nasolaryngoscopy with the otolaryngology team to assess for vocal fold motion impairment
- Status post great vessel, esophageal, or tracheal surgery that could disrupt the recurrent laryngeal nerve
Exclusion Criteria4
- Tracheostomy in place
- Age \>18 years
- History of vocal cord paralysis/paresis
- Patients who cannot have their neck placed in a neutral or slightly extended position due to injury or ligament laxity
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients who are recruited will have an ultrasound performed of their larynx while they are on noninvasive positive pressure ventilation and then a second ultrasound when they are removed from noninvasive positive pressure ventilation. Between the two ultrasounds, the otolaryngology team will perform their fiberoptic nasolaryngoscopy, as per standard unit protocol and patient care.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06406725